WILEX BIOTECHNOLOGY GMBH has a total of 22 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are LOS ANGELES BIOMED RES INST, CT INGENIERIA GENETICA BIOTECH and SLOAN KETTERING INST CANCER.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 6 | |
#2 | Australia | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Brazil | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Computer technology | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Heterocyclic compounds | |
#8 | Healthcare informatics | |
#9 | Specific computer systems | |
#10 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Magdolen Viktor | 12 |
#2 | Wilhelm Olaf | 10 |
#3 | Schmitt Manfred | 10 |
#4 | Kessler Horst | 7 |
#5 | Wilhelm Olaf G | 7 |
#6 | Moroder Luis | 5 |
#7 | Sperl Stefan | 5 |
#8 | Stuerzebecher Joerg | 5 |
#9 | Buergle Markus | 4 |
#10 | Riemer Christoph | 3 |
Publication | Filing date | Title |
---|---|---|
DE10117381A1 | Production of polyclonal, monospecific antibodies against the uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes | |
DE10107707A1 | Antagonists for alpha¶4¶beta¶7¶ integrin | |
DE10013715A1 | New aryl-guanidines with side-chains comprising hydrogen bond donor and acceptor groups, are selective urokinase plasminogen activator inhibitors useful for treating tumors or tumor metastasis | |
DE19940577A1 | Method for training a neural network | |
DE19940389A1 | Selective inhibitors of the urokinase plasminogen activator | |
DE19933701A1 | Cyclic peptidomimetic urokinase receptor antagonists | |
EP1049779A2 | Lh-receptor gene promoter for tissue-specific gene expression | |
EP0982036A1 | Modulation of Beta2 -integrin-mediated cell adhesion |